New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2014
08:49 EDTCOVCovidien says "comfortable" with previously issued guidance
Says optimistic about prospects for remainder of year, on track to deliver a solid operational performance this year. For the next few quarters, says expects growth of general surgical to be negatively impacted by the divestiture of the Confluent biosurgery product line. Says growth of Solitaire is accelerating and should perform better this year than previously expected. Currently expects neurovascular growth to pick up throughout 2014. Says looking at "everything" in terms of acquisitions. Comments made on the Q1 earnings conference call.
News For COV From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for COV

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use